About this trial
Patients with end-stage renal disease (ESRD) who are on dialysis for a long time may experience bladder problems as their urine output decreases and normal bladder filling is lacking. As a result, bladder capacity may be reduced and compliance may deteriorate, which can impact the success of kidney transplantation.
Our prospective observational study is designed to investigate how dialysis duration and residual urine output (diuresis) influence bladder capacity and compliance in ESRD patients who are waiting for kidney transplantation. The adult patients undergoing regular dialysis will be assessed clinically, and they will also be subjected to laboratory tests, imaging, and urodynamic studies.
Through this study, we aim to determine the frequency of bladder malfunction and its correlation with the length of dialysis and the amount of urine excretion. The results might enhance the pre-transplant workup and offer a basis for urological post-transplantation management that could minimize complications.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18-65 years diagnosed with end-stage renal disease (ESRD)
Patients on maintenance dialysis for a duration of 6 to 24 months
ESRD secondary to non-urological causes
Patients awaiting renal transplantation
Disqualifiers
Patients with diabetes mellitus
Patients with neurogenic bladder
Patients with prior urological surgeries
Patients with active urinary tract infection
Trial population
Adult patients with end-stage renal disease (ESRD) on maintenance dialysis and awaiting renal transplantation at Sindh Institute of Urology and Transplantation (SIUT), Karachi.
Trial design
Cohort
Prospective
Treatments tested in this trial
Observational Assessment
Diagnostic testThis is a prospective observational study with no therapeutic or preventive intervention. Participants undergo clinical assessment, including evaluation of dialysis duration and residual urine output, along with laboratory investigations, imaging, and urodynamic studies to assess bladder capacity and compliance.
Treatment groups
Trial outcomes
Primary outcomes
Bladder Capacity
Bladder capacity is measured in milliliters (mL) using video urodynamic study (VUDS) at the time of evaluation, defined as the maximum cystometric capacity at which the patient is given permission to void.
Bladder Compliance
Bladder compliance measured in mL/cm H₂O using a video-urodynamic study is calculated as the change in bladder volume divided by the change in detrusor pressure during the filling phase.
Secondary outcomes
Post-Void Residual Volume
Measured in milliliters (mL) using ultrasound after voiding.
Maximum Urinary Flow Rate (Qmax)
Measured in mL/sec using uroflowmetry.
At baseline evaluation
Presence of lower urinary tract symptoms assessed clinically and recorded as a categorical variable (present or absent).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.